{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T04:24:46Z","timestamp":1741926286046,"version":"3.38.0"},"reference-count":21,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"published-print":{"date-parts":[[2022,3,1]]},"abstract":"<jats:p> We provide an update to the Association of Medical Microbiology and Infectious Disease Canada seasonal influenza foundation guideline on the use of antiviral drugs for influenza for the upcoming 2021\u20132022 influenza season in Canada. Peramivir and baloxavir marboxil were licensed in Canada in 2017 and 2020, respectively, but neither is currently marketed. Thus, this guidance continues to focus on further optimizing the use of oseltamivir and zanamivir. Important issues for this year include the implications of co-circulation of severe acute respiratory syndrome coronavirus 2 and influenza viruses; the role of diagnostic testing in relation to impact on patient management; and dosing and administration recommendations for neuraminidase inhibitors for various at-risk age groups. <\/jats:p>","DOI":"10.3138\/jammi-2022-01-31","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T21:59:36Z","timestamp":1645826376000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["2021\u20132022 AMMI Canada guidance on the use of antiviral drugs for influenza in the COVID-19 pandemic setting in Canada"],"prefix":"10.3138","volume":"7","author":[{"given":"Fred Y","family":"Aoki","sequence":"first","affiliation":[{"name":"Medical Microbiology and Pharmacology and Therapeutics, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Papenburg","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Department of Pediatrics, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Quebec, Canada"},{"name":"Division of Microbiology, Department of Clinical Laboratory Medicine, Montreal Children\u2019s Hospital, McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Mubareka","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upton D","family":"Allen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada"},{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada"},{"name":"Division of Infectious Diseases, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd F","family":"Hatchette","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald A","family":"Evans","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kingston Health Sciences Centre, Queen\u2019s University, Kingston, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1696","reference":[{"issue":"10","key":"r1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.14745\/ccdr.v47i10a02","volume":"47","author":"Nwosu A","year":"2021","journal-title":"Can Commun Dis Rep"},{"key":"r2","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1093\/cid\/ciaa834","volume":"73","author":"Wiese AD","year":"2021","journal-title":"Clin Infect Dis"},{"unstructured":"3. Government of Canada. FluWatch report: July 25 to August 28, 2021 (Weeks 30 to 34). https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/fluwatch\/2020-2021\/weeks-30-34-july-25-august-28-2021.html (Accessed November 10, 2021).","key":"r3"},{"issue":"13","key":"r4","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jama.2020.14661","volume":"324","author":"Solomon DA","year":"2020","journal-title":"JAMA"},{"issue":"9","key":"r5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.micinf.2020.05.016","volume":"22","author":"Zayet S","year":"2020","journal-title":"Microbes Infect"},{"key":"r6","doi-asserted-by":"crossref","first-page":"681469","DOI":"10.3389\/fmed.2021.681469","volume":"8","author":"Dadashi M","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"r7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciy866","volume":"68","author":"Uyeki TM","journal-title":"Clin Infect Dis"},{"issue":"11","key":"r8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/M20-1301","volume":"172","author":"Cheng MP","year":"2020","journal-title":"Ann Intern Med"},{"issue":"4","key":"r9","doi-asserted-by":"crossref","first-page":"e02427","DOI":"10.1128\/JCM.02427-20","volume":"59","author":"Goldfarb DM","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"8","key":"r10","doi-asserted-by":"crossref","first-page":"001404","DOI":"10.1099\/jmm.0.001404","volume":"70","author":"Bergevin MA","year":"2021","journal-title":"J Med Microbiol"},{"issue":"8","key":"r11","first-page":"CD013705","author":"Dinnes J","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"r12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/M17-0848","volume":"167","author":"Merckx J","year":"2017","journal-title":"Ann Intern Med"},{"unstructured":"13. Centers for Disease Control and Prevention. Guide for considering influenze testing when influenza viruses are circulating in the community. https:\/\/www.cdc.gov\/flu\/professionals\/diagnosis\/consider-influenza-testing.htm (Accessed November 10, 2021).","key":"r13"},{"issue":"2","key":"r14","first-page":"60","volume":"4","author":"Aoki FY","year":"2019","journal-title":"J Assoc Med Microbiol Infect Dis Can"},{"key":"r15","first-page":"447","volume-title":"Red book: 2021-2024 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2015","edition":"32"},{"unstructured":"16. Allen UD; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. The use of antiviral drugs for influenza: guidance for practitioners. https:\/\/www.cps.ca\/en\/documents\/position\/antiviral-drugs-for-influenza (Accessed November 1, 2020).","key":"r16"},{"unstructured":"17. Hoffman-La Roche. Product monograph\u00a0: PrTamiflu\u00ae. https:\/\/www.rochecanada.com\/PMs\/Tamiflu\/Tamiflu_PM_E.pdf (Accessed November 10, 2021).","key":"r17"},{"issue":"13","key":"r18","first-page":"1363","volume":"78","author":"Scott LJ","year":"2018","journal-title":"Peramivir: a review in uncomplicated influenza drugs"},{"key":"r19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"Hayden FG","year":"2018","journal-title":"N Engl J Med"},{"volume-title":"Kucers\u2019 the use of antibiotics","author":"Aoki FY.","first-page":"P4580","key":"r20"},{"unstructured":"21. Government of Canada. Influenza weekly reports 2019\u201320 season. https:\/\/www.canada.ca\/en\/public-health\/services\/diseases\/flu-influenza\/influenza-surveillance\/weekly-reports-2019-2020-season.html (Accessed November 10, 2021).","key":"r21"}],"container-title":["Journal of the Association of Medical Microbiology and Infectious Disease Canada"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/jammi-2022-01-31","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T16:23:38Z","timestamp":1741883018000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/jammi-2022-01-31"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3,1]]}},"alternative-id":["10.3138\/jammi-2022-01-31"],"URL":"https:\/\/doi.org\/10.3138\/jammi-2022-01-31","relation":{},"ISSN":["2371-0888","2371-0888"],"issn-type":[{"type":"print","value":"2371-0888"},{"type":"electronic","value":"2371-0888"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}